RxDoctor Payments Data

Christopher Glanton

Nephrology · Kerrville, TXNPI 1609840222

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $30,300 of the $38,597 with a category attached, or 78.5%. Amgen accounts for 97.0% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $21,358 and has fallen 99.9% since, to $15 in 2025. Among nephrology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$38,597in general payments, 2019–2025

Across 117 payments — averaging $329.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$37K
  • Otsuka America Pharmaceutical, Inc.$212
  • Mission Medical Distribution, LLC$182
  • Daiichi Sankyo Inc.$152
  • Mallinckrodt Hospital Products Inc.$138
  • AstraZeneca$120
  • plus $343 from 9 others

What the payments were for

  • Speaking & faculty fees$30,30079%
  • Travel & lodging$6,32516%
  • Food & beverage$1,9345%
  • Education$390%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,597 in reported general payments places this provider in the 90th percentile of 1,070 nephrology providers in Texas.

See all nephrology providers in Texas →

Other nephrology in Kerrville

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →